Status:
RECRUITING
MRI Screening of Placenta Adhesion Abnormalities
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Placenta; Implantation
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Placenta Adhesion Abnormalities (PAA) are the consequence of an excessive invasion of the placenta within the myometrium. PAA are related to severe maternal pregnancy outcomes, especially in case of i...
Eligibility Criteria
Inclusion
- Pregnant participant between 30 and 38 weeks of gestation,
- Age ≥18 years old,
- Participant who completed the preliminary medical examination,
- Participant who has received full information about the organization of the research and has signed her informed consent.
- Participant planning to give birth at CHRU of Nancy
- Participant presenting risk factors for PAA : low-lying or covering placenta or in front of the uterine scar.
Exclusion
- Multiple pregnancy,
- Participant presenting at least one contraindication or restriction to performing an MRI as described in the protocol, in accordance with the current recommendations,
- Participant unable to understand or follow study procedure,
- Person referred to in Articles L. 1121-6 to L. 1121-8, L1122-2 and L. 1122-1-2 of the Public Health Code.
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 21 2026
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04328532
Start Date
October 21 2020
End Date
October 21 2026
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional Universitaire de Nancy
Vandœuvre-lès-Nancy, France, 54500